Loss of muscle mass in sarcopenia patients is associated with an imbalance between muscle protein synthesis and catabolism, and HMB may increase muscle protein synthesis by activating the mammalian target of rapamycin (mTOR) pathway. This evidence concerns the gene MTOR and sarcopenia.